世界の転移性乳がん治療市場2020:企業別、地域別、種類・用途別

【英語タイトル】Global Metastatic Breast Cancer Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが出版した調査資料(GIR20AG09739)・商品コード:GIR20AG09739
・発行会社(調査会社):GlobalInfoResearch
・発行日:2020年7月
・ページ数:104
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥396,720見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥595,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、転移性乳がん治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。転移性乳がん治療の種類別市場規模(化学療法、放射線療法、生物学的標的療法、乳房外科、ホルモン療法)、用途別市場規模(病院、クリニック、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Roche、GlaxoSmithKline、Eli Lilly、Novartis、AstraZeneca、Merck、Bayer、Pfizer、Johnson & Johnson、Sun Pharmaceutical、Gilead Sciences
・地域別グローバル市場分析 2015年-2020年
・転移性乳がん治療の北米市場(アメリカ、カナダ、メキシコ)
・転移性乳がん治療のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・転移性乳がん治療のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・転移性乳がん治療の南米市場(ブラジル、アルゼンチン)
・転移性乳がん治療の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:化学療法、放射線療法、生物学的標的療法、乳房外科、ホルモン療法
・用途別分析:病院、クリニック、その他
・地域別市場規模予測 2021年-2025年
・調査の結果・結論
【レポートの概要】

Market Overview
The global Metastatic Breast Cancer Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Metastatic Breast Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Metastatic Breast Cancer Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Metastatic Breast Cancer Treatment market has been segmented into:
Chemotherapy
Radiation Therapy
Biologic Targeted Therapy
Breast Surgery
Hormone Therapy

By Application, Metastatic Breast Cancer Treatment has been segmented into:
Hospitals
Clinics
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Metastatic Breast Cancer Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Metastatic Breast Cancer Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Metastatic Breast Cancer Treatment market.

The report offers in-depth assessment of the growth and other aspects of the Metastatic Breast Cancer Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Metastatic Breast Cancer Treatment Market Share Analysis
Metastatic Breast Cancer Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Metastatic Breast Cancer Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Metastatic Breast Cancer Treatment sales, revenue and market share for each player covered in this report.

The major players covered in Metastatic Breast Cancer Treatment are:
Roche
GlaxoSmithKline
Eli Lilly
Novartis
AstraZeneca
Merck
Bayer
Pfizer
Johnson & Johnson
Sun Pharmaceutical
Gilead Sciences

【レポートの目次】

Table of Contents

1 Metastatic Breast Cancer Treatment Market Overview
1.1 Product Overview and Scope of Metastatic Breast Cancer Treatment
1.2 Classification of Metastatic Breast Cancer Treatment by Type
1.2.1 Global Metastatic Breast Cancer Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Metastatic Breast Cancer Treatment Revenue Market Share by Type in 2019
1.2.3 Chemotherapy
1.2.4 Radiation Therapy
1.2.5 Biologic Targeted Therapy
1.2.6 Breast Surgery
1.2.7 Hormone Therapy
1.3 Global Metastatic Breast Cancer Treatment Market by Application
1.3.1 Overview: Global Metastatic Breast Cancer Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Metastatic Breast Cancer Treatment Market by Regions
1.4.1 Global Metastatic Breast Cancer Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Metastatic Breast Cancer Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Metastatic Breast Cancer Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Metastatic Breast Cancer Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Metastatic Breast Cancer Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Metastatic Breast Cancer Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Metastatic Breast Cancer Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Metastatic Breast Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 GlaxoSmithKline SWOT Analysis
2.2.4 GlaxoSmithKline Product and Services
2.2.5 GlaxoSmithKline Metastatic Breast Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Eli Lilly
2.3.1 Eli Lilly Details
2.3.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Eli Lilly SWOT Analysis
2.3.4 Eli Lilly Product and Services
2.3.5 Eli Lilly Metastatic Breast Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Metastatic Breast Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 AstraZeneca SWOT Analysis
2.5.4 AstraZeneca Product and Services
2.5.5 AstraZeneca Metastatic Breast Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck SWOT Analysis
2.6.4 Merck Product and Services
2.6.5 Merck Metastatic Breast Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bayer
2.7.1 Bayer Details
2.7.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bayer SWOT Analysis
2.7.4 Bayer Product and Services
2.7.5 Bayer Metastatic Breast Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Pfizer SWOT Analysis
2.8.4 Pfizer Product and Services
2.8.5 Pfizer Metastatic Breast Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Johnson & Johnson
2.9.1 Johnson & Johnson Details
2.9.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Johnson & Johnson SWOT Analysis
2.9.4 Johnson & Johnson Product and Services
2.9.5 Johnson & Johnson Metastatic Breast Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sun Pharmaceutical
2.10.1 Sun Pharmaceutical Details
2.10.2 Sun Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sun Pharmaceutical SWOT Analysis
2.10.4 Sun Pharmaceutical Product and Services
2.10.5 Sun Pharmaceutical Metastatic Breast Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.11 Gilead Sciences
2.11.1 Gilead Sciences Details
2.11.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Gilead Sciences SWOT Analysis
2.11.4 Gilead Sciences Product and Services
2.11.5 Gilead Sciences Metastatic Breast Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Metastatic Breast Cancer Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Metastatic Breast Cancer Treatment Players Market Share
3.2.2 Top 10 Metastatic Breast Cancer Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Metastatic Breast Cancer Treatment Revenue and Market Share by Regions
4.2 North America Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
5 North America Metastatic Breast Cancer Treatment Revenue by Countries
5.1 North America Metastatic Breast Cancer Treatment Revenue by Countries (2015-2020)
5.2 USA Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
6 Europe Metastatic Breast Cancer Treatment Revenue by Countries
6.1 Europe Metastatic Breast Cancer Treatment Revenue by Countries (2015-2020)
6.2 Germany Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
6.4 France Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Metastatic Breast Cancer Treatment Revenue by Countries
7.1 Asia-Pacific Metastatic Breast Cancer Treatment Revenue by Countries (2015-2020)
7.2 China Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
7.5 India Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
8 South America Metastatic Breast Cancer Treatment Revenue by Countries
8.1 South America Metastatic Breast Cancer Treatment Revenue by Countries (2015-2020)
8.2 Brazil Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Metastatic Breast Cancer Treatment by Countries
9.1 Middle East & Africa Metastatic Breast Cancer Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Metastatic Breast Cancer Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Metastatic Breast Cancer Treatment Market Forecast by Type (2019-2024)
10.3 Chemotherapy Revenue Growth Rate (2015-2025)
10.4 Radiation Therapy Revenue Growth Rate (2015-2025)
10.5 Biologic Targeted Therapy Revenue Growth Rate (2015-2025)
10.6 Breast Surgery Revenue Growth Rate (2015-2025)
10.7 Hormone Therapy Revenue Growth Rate (2015-2025)
11 Global Metastatic Breast Cancer Treatment Market Segment by Application
11.1 Global Metastatic Breast Cancer Treatment Revenue Market Share by Application (2015-2020)
11.2 Metastatic Breast Cancer Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Metastatic Breast Cancer Treatment Market Size Forecast (2021-2025)
12.1 Global Metastatic Breast Cancer Treatment Market Size Forecast (2021-2025)
12.2 Global Metastatic Breast Cancer Treatment Market Forecast by Regions (2021-2025)
12.3 North America Metastatic Breast Cancer Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Metastatic Breast Cancer Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Metastatic Breast Cancer Treatment Revenue Market Forecast (2021-2025)
12.6 South America Metastatic Breast Cancer Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Metastatic Breast Cancer Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Metastatic Breast Cancer Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Metastatic Breast Cancer Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Metastatic Breast Cancer Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Metastatic Breast Cancer Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Roche Corporate Information, Location and Competitors
Table 6. Roche Metastatic Breast Cancer Treatment Major Business
Table 7. Roche Metastatic Breast Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Roche SWOT Analysis
Table 9. Roche Metastatic Breast Cancer Treatment Product and Solutions
Table 10. Roche Metastatic Breast Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. GlaxoSmithKline Corporate Information, Location and Competitors
Table 12. GlaxoSmithKline Metastatic Breast Cancer Treatment Major Business
Table 13. GlaxoSmithKline Metastatic Breast Cancer Treatment Total Revenue (USD Million) (2018-2019)
Table 14. GlaxoSmithKline SWOT Analysis
Table 15. GlaxoSmithKline Metastatic Breast Cancer Treatment Product and Solutions
Table 16. GlaxoSmithKline Metastatic Breast Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Eli Lilly Corporate Information, Location and Competitors
Table 18. Eli Lilly Metastatic Breast Cancer Treatment Major Business
Table 19. Eli Lilly Metastatic Breast Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Eli Lilly SWOT Analysis
Table 21. Eli Lilly Metastatic Breast Cancer Treatment Product and Solutions
Table 22. Eli Lilly Metastatic Breast Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Novartis Corporate Information, Location and Competitors
Table 24. Novartis Metastatic Breast Cancer Treatment Major Business
Table 25. Novartis Metastatic Breast Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Novartis SWOT Analysis
Table 27. Novartis Metastatic Breast Cancer Treatment Product and Solutions
Table 28. Novartis Metastatic Breast Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. AstraZeneca Corporate Information, Location and Competitors
Table 30. AstraZeneca Metastatic Breast Cancer Treatment Major Business
Table 31. AstraZeneca Metastatic Breast Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 32. AstraZeneca SWOT Analysis
Table 33. AstraZeneca Metastatic Breast Cancer Treatment Product and Solutions
Table 34. AstraZeneca Metastatic Breast Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Merck Corporate Information, Location and Competitors
Table 36. Merck Metastatic Breast Cancer Treatment Major Business
Table 37. Merck Metastatic Breast Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Merck SWOT Analysis
Table 39. Merck Metastatic Breast Cancer Treatment Product and Solutions
Table 40. Merck Metastatic Breast Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Bayer Corporate Information, Location and Competitors
Table 42. Bayer Metastatic Breast Cancer Treatment Major Business
Table 43. Bayer Metastatic Breast Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Bayer SWOT Analysis
Table 45. Bayer Metastatic Breast Cancer Treatment Product and Solutions
Table 46. Bayer Metastatic Breast Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Pfizer Corporate Information, Location and Competitors
Table 48. Pfizer Metastatic Breast Cancer Treatment Major Business
Table 49. Pfizer Metastatic Breast Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 50. Pfizer SWOT Analysis
Table 51. Pfizer Metastatic Breast Cancer Treatment Product and Solutions
Table 52. Pfizer Metastatic Breast Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Johnson & Johnson Corporate Information, Location and Competitors
Table 54. Johnson & Johnson Metastatic Breast Cancer Treatment Major Business
Table 55. Johnson & Johnson Metastatic Breast Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 56. Johnson & Johnson SWOT Analysis
Table 57. Johnson & Johnson Metastatic Breast Cancer Treatment Product and Solutions
Table 58. Johnson & Johnson Metastatic Breast Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Sun Pharmaceutical Corporate Information, Location and Competitors
Table 60. Sun Pharmaceutical Metastatic Breast Cancer Treatment Major Business
Table 61. Sun Pharmaceutical Metastatic Breast Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 62. Sun Pharmaceutical SWOT Analysis
Table 63. Sun Pharmaceutical Metastatic Breast Cancer Treatment Product and Solutions
Table 64. Sun Pharmaceutical Metastatic Breast Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Gilead Sciences Corporate Information, Location and Competitors
Table 66. Gilead Sciences Metastatic Breast Cancer Treatment Major Business
Table 67. Gilead Sciences Metastatic Breast Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 68. Gilead Sciences SWOT Analysis
Table 69. Gilead Sciences Metastatic Breast Cancer Treatment Product and Solutions
Table 70. Gilead Sciences Metastatic Breast Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Global Metastatic Breast Cancer Treatment Revenue (Million USD) by Players (2015-2020)
Table 72. Global Metastatic Breast Cancer Treatment Revenue Share by Players (2015-2020)
Table 73. Global Metastatic Breast Cancer Treatment Revenue (Million USD) by Regions (2015-2020)
Table 74. Global Metastatic Breast Cancer Treatment Revenue Market Share by Regions (2015-2020)
Table 75. North America Metastatic Breast Cancer Treatment Revenue by Countries (2015-2020)
Table 76. North America Metastatic Breast Cancer Treatment Revenue Market Share by Countries (2015-2020)
Table 77. Europe Metastatic Breast Cancer Treatment Revenue (Million USD) by Countries (2015-2020)
Table 78. Asia-Pacific Metastatic Breast Cancer Treatment Revenue (Million USD) by Countries (2015-2020)
Table 79. South America Metastatic Breast Cancer Treatment Revenue by Countries (2015-2020)
Table 80. South America Metastatic Breast Cancer Treatment Revenue Market Share by Countries (2015-2020)
Table 81. Middle East and Africa Metastatic Breast Cancer Treatment Revenue (Million USD) by Countries (2015-2020)
Table 82. Middle East and Africa Metastatic Breast Cancer Treatment Revenue Market Share by Countries (2015-2020)
Table 83. Global Metastatic Breast Cancer Treatment Revenue (Million USD) by Type (2015-2020)
Table 84. Global Metastatic Breast Cancer Treatment Revenue Share by Type (2015-2020)
Table 85. Global Metastatic Breast Cancer Treatment Revenue Forecast by Type (2021-2025)
Table 86. Global Metastatic Breast Cancer Treatment Revenue by Application (2015-2020)
Table 87. Global Metastatic Breast Cancer Treatment Revenue Share by Application (2015-2020)
Table 88. Global Metastatic Breast Cancer Treatment Revenue Forecast by Application (2021-2025)
Table 89. Global Metastatic Breast Cancer Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Metastatic Breast Cancer Treatment Picture
Figure 2. Global Metastatic Breast Cancer Treatment Revenue Market Share by Type in 2019
Figure 3. Chemotherapy Picture
Figure 4. Radiation Therapy Picture
Figure 5. Biologic Targeted Therapy Picture
Figure 6. Breast Surgery Picture
Figure 7. Hormone Therapy Picture
Figure 8. Metastatic Breast Cancer Treatment Revenue Market Share by Application in 2019
Figure 9. Hospitals Picture
Figure 10. Clinics Picture
Figure 11. Other Picture
Figure 12. Global Metastatic Breast Cancer Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Metastatic Breast Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Metastatic Breast Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Metastatic Breast Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Metastatic Breast Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Metastatic Breast Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Metastatic Breast Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Metastatic Breast Cancer Treatment Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Metastatic Breast Cancer Treatment Revenue Market Share in 2019
Figure 21. Global Top 10 Players Metastatic Breast Cancer Treatment Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Metastatic Breast Cancer Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Metastatic Breast Cancer Treatment Revenue Market Share by Regions (2015-2020)
Figure 25. Global Metastatic Breast Cancer Treatment Revenue Market Share by Regions in 2018
Figure 26. North America Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Europe Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 29. South America Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 31. North America Metastatic Breast Cancer Treatment Revenue Market Share by Countries (2015-2020)
Figure 32. North America Metastatic Breast Cancer Treatment Revenue Market Share by Countries in 2019
Figure 33. USA Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Canada Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 36. Europe Metastatic Breast Cancer Treatment Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Metastatic Breast Cancer Treatment Revenue Market Share by Countries in 2019
Figure 38. Germany Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 39. UK Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 40. France Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Russia Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Italy Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Metastatic Breast Cancer Treatment Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Metastatic Breast Cancer Treatment Revenue Market Share by Countries in 2019
Figure 45. China Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Japan Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Korea Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 48. India Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 50. South America Metastatic Breast Cancer Treatment Revenue Market Share by Countries (2015-2020)
Figure 51. South America Metastatic Breast Cancer Treatment Revenue Market Share by Countries in 2019
Figure 52. Brazil Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Metastatic Breast Cancer Treatment Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Metastatic Breast Cancer Treatment Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 57. UAE Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Metastatic Breast Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 60. Global Metastatic Breast Cancer Treatment Revenue Share by Type (2015-2020)
Figure 61. Global Metastatic Breast Cancer Treatment Revenue Share by Type in 2019
Figure 62. Global Metastatic Breast Cancer Treatment Market Share Forecast by Type (2021-2025)
Figure 63. Global Chemotherapy Revenue Growth Rate (2015-2020)
Figure 64. Global Radiation Therapy Revenue Growth Rate (2015-2020)
Figure 65. Global Biologic Targeted Therapy Revenue Growth Rate (2015-2020)
Figure 66. Global Breast Surgery Revenue Growth Rate (2015-2020)
Figure 67. Global Hormone Therapy Revenue Growth Rate (2015-2020)
Figure 68. Global Metastatic Breast Cancer Treatment Revenue Share by Application (2015-2020)
Figure 69. Global Metastatic Breast Cancer Treatment Revenue Share by Application in 2019
Figure 70. Global Metastatic Breast Cancer Treatment Market Share Forecast by Application (2021-2025)
Figure 71. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 72. Global Clinics Revenue Growth Rate (2015-2020)
Figure 73. Global Other Revenue Growth Rate (2015-2020)
Figure 74. Global Metastatic Breast Cancer Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Metastatic Breast Cancer Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Metastatic Breast Cancer Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Metastatic Breast Cancer Treatment Revenue Market Forecast (2021-2025)
Figure 78. Europe Metastatic Breast Cancer Treatment Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Metastatic Breast Cancer Treatment Revenue Market Forecast (2021-2025)
Figure 80. South America Metastatic Breast Cancer Treatment Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Metastatic Breast Cancer Treatment Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel


★調査レポート[世界の転移性乳がん治療市場2020:企業別、地域別、種類・用途別] (コード:GIR20AG09739)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の転移性乳がん治療市場2020:企業別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆